parkinson’s disease
-
basal ganglia, Brain, deep brain stimulation, iTBS, MDS-UPDRS, Neurodegenerative Diseases, Neuromodulation, neuroscience, Neurostimulation, non invasive brain stimulation, parkinson’s disease, putamen, temporal interference stimulation, tTISTranscranial Temporal Interference Stimulation (tTIS) May Improve Parkinson’s Motor Symptoms
Deep brain stimulation works for Parkinson’s, but it requires implanted electrodes. A…
-
alpha-synuclein, ambroxol, biomarker, Brain, exenatide, exercise, GLP-1 agonist, Neurodegenerative Diseases, parkinson’s disease, Prevention, prodromal, Psychology, RBD, REM sleep behavior disorder, sleepParkinson’s Disease Prevention: Prodromal Symptoms, RBD, Early Intervention Trials
Parkinson’s disease has a years-to-decades prodromal stage where motor symptoms haven’t yet…
-
exenatide, GLP-1, lixisenatide, network meta-analysis, Neurodegenerative Diseases, neurology, neuroprotection, neuroscience, Ozempic, parkinson’s diseaseCan GLP-1 Drugs Slow Parkinson’s Disease? Evidence from 5 Trials
Research Highlights GLP-1 receptor agonists are diabetes drugs (Ozempic, Trulicity, Byetta) being…
-
bdnf, bdnf gene, dopamine, dopamine neurons, Drugs, gene therapy, genetics, motor behavior, motor symptoms, Neurodegenerative Diseases, parkinson’s disease, pramiprexole, transfectionBDNF Gene Transfection & Pramiprexole Combo Effectively Treat Parkinson’s Disease in Rat Models (2024 Study)
Parkinson’s disease (PD), a degenerative disorder that predominantly affects the motor system,…
